Technical Assistance - Siemens IMMULITE 2000 Manual De Instrucciones

Alternate Sample Type: To assess the
effect of alternate sample types, blood
was collected from 33 volunteers into
plain, heparinized, and Becton Dickinson
®
SST Vacutainer tubes. Equal volumes of
the matched samples were spiked with
various concentrations of estradiol, to
obtain values throughout the calibration
range of the assay, and then assayed by
the IMMULITE 2000 Estradiol procedure.
(Heparin) = 0.98 (Serum) + 11 pg/mL
r = 0.996
(SST) = 0.98 (Plain Tubes) + 15 pg/mL
r = 0.994
Means:
476 pg/mL (Serum)
477 pg/mL (Heparin)
482 pg/mL (SST)
Method Comparison: The assay was
compared to IMMULITE Estradiol on
97 samples. (Concentration range:
approximately 20 to 1800 pg/mL. See
graph.) By linear regression:
(IML 2000) = 0.90 (IML) + 18 pg/mL
r = 0.990
Means:
337 pg/mL (IMMULITE 2000)
354 pg/mL (IMMULITE)
References
1) Batzer F. Hormonal evaluation of early
pregnancy. Fertil Steril 1980;34:1–13.
2) Bergquist C, Nillius SJ, Wide L. Human
gonadotropin therapy: 1. Serum estradiol and
progesterone patterns during conceptual cycles.
Fertil Steril 1983;39:761–5. 3) Erickson GF.
Normal ovarian function. Clin Obstet Gynecol
1978;21:31–52. 4) Garcia JE, Jones GS, Wright
GL. Prediction of the time of ovulation. Fertil Steril
1981;36:308–15. 5) Gautray JP, et al. Clinical
investigation of the menstrual cycle: 3. Clinical,
endometrial, and endocrine aspects of luteal
defect. Fertil Steril 1981;35:296–303.
6) Goebelsmann U, Mishell DR. The menstrual
cycle. In: Mishell DR, Davajan V, editors.
Reproductive endocrinology, infertility and
contraception. Philadelphia: Davis FA, 1979:
67–89. 7) Goldstein D, et al. Correlation between
estradiol and progesterone in cycles with luteal
phase deficiency. Fertil Steril 1982;37:348–54.
8) Haning RV, et al. Plasma estradiol is superior
to ultrasound and urinary estriol glucuronide as a
predictor of ovarian hyperstimulation during
induction of ovulation with menotropins. Fertil
Steril 1983;40:31–6. 9) Judd HL, Korenman SG.
Effects of aging on reproductive function in
women. In: Korenman SG, editor. Endocrine
aspects of aging. New York: Elsevier Biomedical,
1982:163–97. 10) Landgren BM, Aedo AR,
Diczfalusy E. Hormonal changes associated with
6
ovulation and luteal function. In: Flamigini C,
Givens JR, editors. The gonadotropins: basic
science and clinical aspects in females. London:
Academic Press, 1982:187–201. 11) March CM,
Goebelsmann U, Nakamura RM, Mishell DR.
Roles of estradiol and progesterone in eliciting the
midcycle luteinizing hormone and follicle-
stimulating hormone surges. J Clin Endocrinol
Metab 1979;49:507–12. 12) Polan ML, et al.
Abnormal ovarian cycles as diagnosed by
ultrasound and serum estradiol levels. Fertil Steril
1982; 37:342–7. 13) Radwanska E, et al. Plasma
progesterone and oestradiol estimation in the
diagnosis and treatment of luteal insufficiency in
menstruating infertile women. Acta Eur Fertil
1976;39–47. 14) Radwanska E, et al. Correlation
between preovulatory serum estradiol and
midluteal progesterone levels during induction of
ovulation with clomid and HCG. J Reprod Med
1980; 24:79–82. 15) Rebar RW, Yen SSC.
Endocrine rhythms in gonadotropins and ovarian
steroids with reference to reproductive processes.
In: Krieger, editor. Endocrine rhythms. New York:
Raven Press, 1979: 259–98. 16) Robertson RD,
et al. Assessment of ovulation by ultrasound and
plasma estradiol determinations. Obstet Gynecol
1979; 54:686–90. 17) Siiteri PK, Febres F.
Ovarian hormone synthesis, circulation, and
mechanisms of action. In: DeGroot L, et al,
editors. Endocrinology, vol 3. New York: Grune &
Stratton, 1979:1401–17. 18) Burtis CA, Ashwood
ER, editors. Tietz textbook of clinical chemistry.
2nd ed. Philadelphia: W.B. Saunders, 1994.
19) National Committee for Clinical Laboratory
Standards. Procedures for the collection of
diagnostic blood specimens by venipuncture;
approved standard. 4th ed. NCCLS Document
H3-A4, Wayne, PA: NCCLS, 1998. 20) Centers
for Disease Control. Update: Universal
precautions for prevention of transmission of
human immunodeficiency virus, hepatitis B virus
and other bloodborne pathogens in healthcare
settings. MMWR, 1988;37:377–82, 387–8.
21) Clinical and Laboratory Standards Institute
(formerly NCCLS). Protection of Laboratory
Workers From Occupationally Acquired
Infections; Approved Guideline - Third Edition.
Wayne, PA: Clinical and Laboratory Standards
Institute; 2005. NCCLS Document M29-A3.
22) Federal Occupational Safety and Health
Administration, Bloodborne Pathogens
Standard, 29 CFR 1910.1030.

Technical Assistance

Available outside the United States only.
For technical assistance, contact your
National Distributor.
www.siemens.com/diagnostics
The Quality System of Siemens Healthcare
Diagnostics Products Ltd. is certified to ISO
13485:2003.
IMMULITE 2000 Estradiol (PIL2KE2-28, 2016-05-23)